STOK logo

Stoke Therapeutics, Inc. (STOK) Cash From Operations

Annual CFO:

-$86.85M-$5.78M(-7.13%)
December 31, 2024

Summary

  • As of today, STOK annual cash from operations is -$86.85 million, with the most recent change of -$5.78 million (-7.13%) on December 31, 2024.
  • During the last 3 years, STOK annual cash from operations has fallen by -$19.94 million (-29.81%).
  • STOK annual cash from operations is now -1513.13% below its all-time high of -$5.38 million, reached on December 31, 2017.

Performance

STOK Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

Quarterly CFO:

-$30.37M-$4.94M(-19.45%)
September 30, 2025

Summary

  • As of today, STOK quarterly cash from operations is -$30.37 million, with the most recent change of -$4.94 million (-19.45%) on September 30, 2025.
  • Over the past year, STOK quarterly cash from operations has dropped by -$8.75 million (-40.49%).
  • STOK quarterly cash from operations is now -123.03% below its all-time high of $131.83 million, reached on March 31, 2025.

Performance

STOK Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

TTM CFO:

$52.85M-$8.75M(-14.21%)
September 30, 2025

Summary

  • As of today, STOK TTM cash from operations is $52.85 million, with the most recent change of -$8.75 million (-14.21%) on September 30, 2025.
  • Over the past year, STOK TTM cash from operations has increased by +$137.15 million (+162.68%).
  • STOK TTM cash from operations is now -24.01% below its all-time high of $69.54 million, reached on March 31, 2025.

Performance

STOK TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

STOK Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-7.1%-40.5%+162.7%
3Y3 Years-29.8%-37.7%+305.2%
5Y5 Years-179.7%-170.3%+226.3%

STOK Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-172.6%at low-123.0%at low-24.0%+160.3%
5Y5-Year-179.7%at low-123.0%at low-24.0%+160.3%
All-TimeAll-Time-1513.1%at low-123.0%at low-24.0%+160.3%

STOK Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$30.37M(-19.4%)
$52.85M(-14.2%)
Jun 2025
-
-$25.42M(-119.3%)
$61.60M(-11.4%)
Mar 2025
-
$131.83M(+668.4%)
$69.54M(+180.1%)
Dec 2024
-$86.85M(-7.1%)
-$23.19M(-7.3%)
-$86.85M(-3.0%)
Sep 2024
-
-$21.61M(-23.7%)
-$84.31M(-5.4%)
Jun 2024
-
-$17.48M(+28.9%)
-$79.95M(+5.1%)
Mar 2024
-
-$24.57M(-19.0%)
-$84.28M(-4.0%)
Dec 2023
-$81.07M(-154.4%)
-$20.65M(-19.6%)
-$81.07M(+2.1%)
Sep 2023
-
-$17.26M(+20.8%)
-$82.79M(+5.5%)
Jun 2023
-
-$21.80M(-2.1%)
-$87.58M(-2.2%)
Mar 2023
-
-$21.36M(+4.5%)
-$85.71M(-169.0%)
Dec 2022
-$31.87M(+52.4%)
-$22.37M(-1.4%)
-$31.87M(-23.7%)
Sep 2022
-
-$22.06M(-10.7%)
-$25.75M(-40.1%)
Jun 2022
-
-$19.93M(-161.3%)
-$18.38M(-28.7%)
Mar 2022
-
$32.49M(+299.8%)
-$14.28M(+78.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$66.91M(-58.5%)
-$16.26M(-10.7%)
-$66.91M(-9.0%)
Sep 2021
-
-$14.68M(+7.3%)
-$61.40M(-6.0%)
Jun 2021
-
-$15.83M(+21.4%)
-$57.95M(-11.9%)
Mar 2021
-
-$20.14M(-87.3%)
-$51.77M(-22.1%)
Dec 2020
-$42.22M(-36.0%)
-$10.75M(+4.3%)
-$42.40M(-1.3%)
Sep 2020
-
-$11.23M(-16.5%)
-$41.85M(-8.2%)
Jun 2020
-
-$9.65M(+10.4%)
-$38.67M(-9.6%)
Mar 2020
-
-$10.77M(-5.6%)
-$35.29M(-13.6%)
Dec 2019
-$31.05M(-183.2%)
-$10.20M(-26.8%)
-$31.05M(-48.9%)
Sep 2019
-
-$8.05M(-28.3%)
-$20.85M(-62.8%)
Jun 2019
-
-$6.27M(+3.9%)
-$12.81M(-96.1%)
Mar 2019
-
-$6.53M(-228.4%)
-$6.53M(-228.4%)
Dec 2018
-$10.96M(-103.6%)
-
-
Mar 2018
-
-$1.99M
-$1.99M
Dec 2017
-$5.38M
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual cash from operations year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly cash from operations year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM cash from operations year-on-year change?

What is Stoke Therapeutics, Inc. annual cash from operations?

The current annual cash from operations of STOK is -$86.85M

What is the all-time high annual cash from operations for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual cash from operations is -$5.38M

What is Stoke Therapeutics, Inc. annual cash from operations year-on-year change?

Over the past year, STOK annual cash from operations has changed by -$5.78M (-7.13%)

What is Stoke Therapeutics, Inc. quarterly cash from operations?

The current quarterly cash from operations of STOK is -$30.37M

What is the all-time high quarterly cash from operations for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly cash from operations is $131.83M

What is Stoke Therapeutics, Inc. quarterly cash from operations year-on-year change?

Over the past year, STOK quarterly cash from operations has changed by -$8.75M (-40.49%)

What is Stoke Therapeutics, Inc. TTM cash from operations?

The current TTM cash from operations of STOK is $52.85M

What is the all-time high TTM cash from operations for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM cash from operations is $69.54M

What is Stoke Therapeutics, Inc. TTM cash from operations year-on-year change?

Over the past year, STOK TTM cash from operations has changed by +$137.15M (+162.68%)
On this page